KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Short-Term Debt issuances (2017 - 2025)

Johnson & Johnson's Short-Term Debt issuances history spans 17 years, with the latest figure at $3.9 billion for Q4 2025.

  • For Q4 2025, Short-Term Debt issuances rose 18.83% year-over-year to $3.9 billion; the TTM value through Dec 2025 reached $14.6 billion, down 4.52%, while the annual FY2025 figure was $14.6 billion, 4.52% down from the prior year.
  • Short-Term Debt issuances for Q4 2025 was $3.9 billion at Johnson & Johnson, up from $1.3 billion in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $14.9 billion in Q1 2023 and bottomed at -$2.0 billion in Q3 2024.
  • The 5-year median for Short-Term Debt issuances is $1.3 billion (2023), against an average of $3.5 billion.
  • The largest annual shift saw Short-Term Debt issuances soared 13026.09% in 2022 before it tumbled 926.56% in 2024.
  • A 5-year view of Short-Term Debt issuances shows it stood at $785.0 million in 2021, then skyrocketed by 284.59% to $3.0 billion in 2022, then tumbled by 57.57% to $1.3 billion in 2023, then soared by 157.06% to $3.3 billion in 2024, then increased by 18.83% to $3.9 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Short-Term Debt issuances are $3.9 billion (Q4 2025), $1.3 billion (Q3 2025), and $565.0 million (Q2 2025).